Correction: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis
Kevin Y. Xu, Jennifer K. Bello, Joanna Buss, Hendrée E. Jones, Laura J. Bierut, Dustin Stwalley, Hannah S. Szlyk, Caitlin E. Martin, Jeannie C. Kelly, Ebony B. Carter, Elizabeth E. Krans, Richard A. Grucza
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOpioid Use Disorder Treatment · Prenatal Substance Exposure Effects
Correction: Addict Sci Clin Pract 20, 1 (2025)
10.1186/s13722-024-00530-1
Following publication of the original article [1], the authors noticed an error in the language used to describe the cohort development protocol, as well as the associated Fig. 1.
In the Data sources and cohort development section, one sentence is changed from:
“People who initiated BUP or PSY before pregnancy (n = 4,396) were excluded, thus limiting our sample of participants to those who newly initiated BUP or PSY during pregnancy.”
To:
People who initiated BUP or PSY after delivery (n = 4,396) were excluded, thus limiting our sample of participants to those who newly initiated BUP or PSY during pregnancy.
Fig. 1 is changed from:
Fig. 1. Derivation of the analytic sample
To:
Fig. 1. Derivation of the analytic sample
The authors apologise for this error and regret any inconvenience caused.
The original article [1] has been updated.